UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Management Guidelines of Eosinophilic Esophagitis in Childhood

Journal of pediatric gastroenterology and nutrition, 2014-01, Vol.58 (1), p.107-118

2014

Volltextzugriff (PDF)

Diagnostic Approach and Management of Cowʼs-Milk Protein Allergy in Infants and Children: ESPGHAN GI Committee Practical Guidelines

Journal of pediatric gastroenterology and nutrition, 2012-08, Vol.55 (2), p.221-229

2012

Volltextzugriff (PDF)

A Practical Guide for the Diagnosis of Primary Enteric Nervous System Disorders

Journal of pediatric gastroenterology and nutrition, 2013-11, Vol.57 (5), p.677-686

2013

Volltextzugriff (PDF)

Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease

Journal of Crohn's and colitis, 2014-10, Vol.8 (10), p.1179-1207

2014

Volltextzugriff (PDF)

Diagnostic Approach and Management of Cow's‐Milk Protein Allergy in Infants and Children

Journal of pediatric gastroenterology and nutrition, 2012-08, Vol.55 (2), p.221-229

2012

Volltextzugriff (PDF)

Severe Food Allergy as a Variant of IPEX Syndrome Caused by a Deletion in a Noncoding Region of the FOXP3 Gene

Gastroenterology (New York, N.Y. 1943), 2007-05, Vol.132 (5), p.1705-1717

2007

Volltextzugriff (PDF)

Compartmentalized expression of Th1 and Th17 cytokines in pediatric inflammatory bowel diseases

Inflammatory bowel diseases, 2012-07, Vol.18 (7), p.1260-1266

2012

Volltextzugriff (PDF)

The Susceptibility to Fas-Induced Apoptosis in Normal Enterocytes Is Regulated on the Level of cIAP1 and 2

Biochemical and biophysical research communications, 2002-02, Vol.290 (4), p.1308-1314

2002

Volltextzugriff (PDF)

Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome

British journal of dermatology (1951), 2009-03, Vol.160 (3), p.645-651

2009

Volltextzugriff (PDF)

Efficacy of adalimumab as first-line therapy in pediatric Crohn's disease

Digestive and liver disease, 2017-10, Vol.49 (4), p.e261-e261

2017

Volltextzugriff (PDF)

Efficacy of methotrexate in pediatric Crohn's disease: A French multicenter study

Inflammatory bowel diseases, 2006-11, Vol.12 (11), p.1053-1057

2006

Volltextzugriff (PDF)

Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway

Gut, 2003-01, Vol.52 (1), p.94-100

2003

Volltextzugriff (PDF)

Interleukin-17 is a potent immuno-modulator and regulator of normal human intestinal epithelial cell growth

Biochemical and biophysical research communications, 2005-11, Vol.337 (2), p.505-509

2005

Volltextzugriff (PDF)

Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop

Journal of cellular physiology, 2006-11, Vol.209 (2), p.241-252

2006

Volltextzugriff (PDF)

Lipopolysaccharide modulation of normal enterocyte turnover by toll-like receptors is mediated by endogenously produced tumour necrosis factor α

Gut, 2002-12, Vol.51 (6), p.842-848

2002

Volltextzugriff (PDF)

P385 Relationship between adalimumab concentration and efficacy for the induction of clinical remission in pediatric patients with moderate to severe Crohn's disease

Journal of Crohn's and colitis, 2013-02, Vol.7, p.S164-S164

2013

Volltextzugriff (PDF)

P384 Relationship between adalimumab concentration and efficacy for the maintenance of clinical remission in pediatric patients with moderate to severe Crohn's disease

Journal of Crohn's and colitis, 2013-02, Vol.7, p.S163-S163

2013

Volltextzugriff (PDF)

Severe Dysimmune Cytopenia in Children Treated with Tacrolimus After Organ Transplantation

American journal of transplantation, 2006-05, Vol.6 (5p1), p.1072-1076

2006

Volltextzugriff (PDF)

Les perspectives thérapeutiques

Pathologie biologie (Paris), 2013-06, Vol.61 (3), p.e61-e64

2013

Volltextzugriff (PDF)

P411 Pharmacokinetics of adalimumab in pediatric patients with moderate to severe Crohn's disease

Journal of Crohn's and colitis, 2013-02, Vol.7, p.S174-S174

2013

Volltextzugriff (PDF)

Pro-inflammatory environment dictates the IL-17-producing capacity of human invariant NKT cells

The Journal of immunology (1950), 2011, Vol.186, p.5758-5765

2011

Volltextzugriff (PDF)

P223 Improved work productivity in caregivers of pediatric patients with Crohn's disease treated with adalimumab

Journal of Crohn's and colitis, 2013-02, Vol.7, p.S99-S99

2013

Volltextzugriff (PDF)

P311 Adalimumab treatment is associated with improved quality of life in pediatric Crohn's disease

Journal of Crohn's and colitis, 2013-02, Vol.7, p.S133-S134

2013

Volltextzugriff (PDF)

15 Serious infections and associated risk factors in patients receiving infliximab and immunotherapies for children with inflammatory bowel disease: DEVELOP registry data

Journal of Crohn's and colitis, 2013-02, Vol.7, p.S7-S8

2013

Volltextzugriff (PDF)

P436 Malignancies in children receiving infliximab and other inflammatory bowel disease therapies: an inflammatory bowel disease multicenter, prospective, long-term registry of pediatric patients (DEVELOP) registry data

Journal of Crohn's and colitis, 2013-02, Vol.7, p.S184-S185

2013

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(30)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(14)
Life Sciences & Biomedicine
(13)
Science & Technology
(13)
Child
(8)
Gastroenterology & Hepatology
(8)
Apoptosis - Drug Effects
(5)
Biological And Medical Sciences
(5)
Male
(5)
Female
(4)
Infant
(4)
Medical Sciences
(4)
Rna, Messenger - Genetics
(4)
Adolescent
(3)
Cell Line
(3)
Crohn's Disease
(3)
Nutrition & Dietetics
(3)
Pediatric
(3)
Pediatrics
(3)
Rna, Messenger - Metabolism
(3)
Adrenal Cortex Hormones - Therapeutic Use
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Management Guidelines of Eosinophilic Esophagitis in Childhood

Diagnostic Approach and Management of Cowʼs-Milk Protein Allergy in Infants and Children: ESPGHAN GI Committee Practical Guidelines

A Practical Guide for the Diagnosis of Primary Enteric Nervous System Disorders

Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease

Diagnostic Approach and Management of Cow's‐Milk Protein Allergy in Infants and Children

Severe Food Allergy as a Variant of IPEX Syndrome Caused by a Deletion in a Noncoding Region of the FOXP3 Gene

Compartmentalized expression of Th1 and Th17 cytokines in pediatric inflammatory bowel diseases

The Susceptibility to Fas-Induced Apoptosis in Normal Enterocytes Is Regulated on the Level of cIAP1 and 2

Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome

Efficacy of adalimumab as first-line therapy in pediatric Crohn's disease

Efficacy of methotrexate in pediatric Crohn's disease: A French multicenter study

Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway

Interleukin-17 is a potent immuno-modulator and regulator of normal human intestinal epithelial cell growth

Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop

Lipopolysaccharide modulation of normal enterocyte turnover by toll-like receptors is mediated by endogenously produced tumour necrosis factor α

P385 Relationship between adalimumab concentration and efficacy for the induction of clinical remission in pediatric patients with moderate to severe Crohn's disease

P384 Relationship between adalimumab concentration and efficacy for the maintenance of clinical remission in pediatric patients with moderate to severe Crohn's disease

Severe Dysimmune Cytopenia in Children Treated with Tacrolimus After Organ Transplantation

Les perspectives thérapeutiques

P411 Pharmacokinetics of adalimumab in pediatric patients with moderate to severe Crohn's disease

Pro-inflammatory environment dictates the IL-17-producing capacity of human invariant NKT cells

P223 Improved work productivity in caregivers of pediatric patients with Crohn's disease treated with adalimumab

P311 Adalimumab treatment is associated with improved quality of life in pediatric Crohn's disease

15 Serious infections and associated risk factors in patients receiving infliximab and immunotherapies for children with inflammatory bowel disease: DEVELOP registry data

P436 Malignancies in children receiving infliximab and other inflammatory bowel disease therapies: an inflammatory bowel disease multicenter, prospective, long-term registry of pediatric patients (DEVELOP) registry data

Suchergebnisse filtern